These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34442810)

  • 41. Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters.
    Yuan S; Yin X; Meng X; Chan J; Ye ZW; Riva L; Pache L; Chan CC; Lai PM; Chan C; Poon V; Matsunaga N; Pu Y; Yuen CK; Cao J; Liang R; Tang K; Sheng L; Du Y; Xu W; Sze KH; Zhang J; Chu H; Kok KH; To K; Jin DY; Sun R; Chanda S; Yuen KY
    Res Sq; 2020 Oct; ():. PubMed ID: 33052331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture.
    Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity.
    Herrmann A; Gege C; Wangen C; Wagner S; Kögler M; Cordsmeier A; Irrgang P; Ip WH; Weil T; Hunszinger V; Groß R; Heinen N; Pfaender S; Reuter S; Klopfleisch R; Uhlig N; Eberlein V; Issmail L; Grunwald T; Hietel B; Cynis H; Münch J; Sparrer KMJ; Ensser A; Tenbusch M; Dobner T; Vitt D; Kohlhof H; Hahn F
    Antiviral Res; 2024 Sep; 231():106008. PubMed ID: 39306285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
    Santos IA; Grosche VR; Bergamini FRG; Sabino-Silva R; Jardim ACG
    Front Microbiol; 2020; 11():1818. PubMed ID: 32903349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives.
    Koma T; Adachi S; Doi N; Adachi A; Nomaguchi M
    Front Microbiol; 2020; 11():2016. PubMed ID: 32983025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity.
    Nizi MG; Persoons L; Corona A; Felicetti T; Cernicchi G; Massari S; Manfroni G; Vangeel L; Barreca ML; Esposito F; Jochmans D; Milia J; Cecchetti V; Schols D; Neyts J; Tramontano E; Sabatini S; De Jonghe S; Tabarrini O
    ACS Med Chem Lett; 2022 May; 13(5):855-864. PubMed ID: 35571875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral.
    Jimenez-Aleman GH; Castro V; Londaitsbehere A; Gutierrez-Rodríguez M; Garaigorta U; Solano R; Gastaminza P
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia.
    Niemeyer BF; Miller CM; Ledesma-Feliciano C; Morrison JH; Jimenez-Valdes R; Clifton C; Poeschla EM; Benam KH
    Nano Sel; 2022 Feb; 3(2):437-449. PubMed ID: 34541574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies.
    Su X; Huang Z; Xu W; Wang Q; Xing L; Lu L; Jiang S; Xia S
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery and Optimization of Novel
    Zhou X; Gou K; Xu J; Jian L; Luo Y; Li C; Guan X; Qiu J; Zou J; Zhang Y; Zhong X; Zeng T; Zhou Y; Xiao Y; Yang X; Chen W; Gao P; Liu C; Zhou Y; Tao L; Liu X; Cen X; Chen Q; Sun Q; Luo Y; Zhao Y
    J Med Chem; 2023 Nov; 66(21):14755-14786. PubMed ID: 37870434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
    Bojkova D; Costa R; Reus P; Bechtel M; Jaboreck MC; Olmer R; Martin U; Ciesek S; Michaelis M; Cinatl J
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host directed therapies: COVID-19 and beyond.
    Tripathi D; Sodani M; Gupta PK; Kulkarni S
    Curr Res Pharmacol Drug Discov; 2021; 2():100058. PubMed ID: 34870156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia.
    Gaidano V; Houshmand M; Vitale N; Carrà G; Morotti A; Tenace V; Rapelli S; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Cilloni D; Cignetti A; Saglio G; Circosta P
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33670894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2.
    Wali L; Karbiener M; Chou S; Kovtunyk V; Adonyi A; Gösler I; Contreras X; Stoeva D; Blaas D; Stöckl J; Kreil TR; Gualdoni GA; Gorki AD
    J Virus Erad; 2022 Dec; 8(4):100305. PubMed ID: 36514716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2.
    Purificação AD; Silva-Mendonça S; Cruz LV; Sacramento CQ; Temerozo JR; Fintelman-Rodrigues N; de Freitas CS; Godoi BF; Vaidergorn MM; Leite JA; Salazar Alvarez LC; Freitas MV; Silvac MFB; Martin BA; Lopez RFV; Neves BJ; Costa FTM; Souza TML; da Silva Emery F; Andrade CH; Nonato MC
    ACS Omega; 2024 Mar; 9(10):11418-11430. PubMed ID: 38496952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses.
    Leung AKL; Griffin DE; Bosch J; Fehr AR
    Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic.
    Shih PC; Mao YW; Hu JW; Hsieh HY; Shih TM; Lu LP; Chang WH; Huang CH; Lin CH; Lin CH; Tan P; Yang YC; Chien MH; Su CC; Yeh CH; Chuang PY; Hsieh TL; Wang CC; Hsieh PS; Chou TY; Tsai GE
    ACS Pharmacol Transl Sci; 2022 Jun; 5(6):400-412. PubMed ID: 37582235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.
    Shapira T; Vimalanathan S; Rens C; Pichler V; Peña-Díaz S; Jordana G; Rees W; Winkler DFH; Sarai I; Steiner T; Jean F; Pelech S; Av-Gay Y
    Mol Biomed; 2022 Dec; 3(1):43. PubMed ID: 36508083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a machine learning-based target-specific scoring function for structure-based binding affinity prediction for human dihydroorotate dehydrogenase inhibitors.
    Meng J; Zhang L; He Z; Hu M; Liu J; Bao W; Tian Q; Feng H; Liu H
    J Comput Chem; 2024 Sep; ():. PubMed ID: 39325045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Engineering of Laser-Induced Graphene for Potential-Driven Broad-Spectrum Antimicrobial and Antiviral Applications.
    Gu M; Huang L; Wang Z; Guo W; Cheng L; Yuan Y; Zhou Z; Hu L; Chen S; Shen C; Tang BZ; Ye R
    Small; 2021 Dec; 17(51):e2102841. PubMed ID: 34672086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.